Skip to content

Comparing between prescription and not prescription of vitamin D on recurrence of endometriosis related pains

Comparing between prescription and not prescription of vitamin D on recurrence of endometriosis related pains, after laparoscopic surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013021912151N3
Enrollment
22
Registered
2014-09-23
Start date
2014-09-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis of pelvic peritoneum. Endometriosis of pelvic peritoneum

Interventions

Intervention 1: In intervention group oral pearls of vitamin D ( 50000 IU - Dana Tabriz Company-Iran ) per week until 16 weeks after operation will be prescribed. Intervention 2: in control group one
Treatment - Drugs
Placebo
In intervention group oral pearls of vitamin D ( 50000 IU - Dana Tabriz Company-Iran ) per week until 16 weeks after operation will be prescribed.
in control group one oral pearl of placebo ( 50000 IU - Dana Tabriz Company-Iran ) weekly until 16 weeks.

Sponsors

Minimally Invasive Surgery Research Center of Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : 15-45 years women that during laparoscopy endometriosis is confirmed and in second menstruation after operation the score of pain for dysmenorrhea or pelvic pain will be 3 or more. Exclusion criteria : The women that have received vitamin D in last 6 months, the women that will not continue the follow up.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of dysmenorrhea. Timepoint: 2 cycles after operation. Method of measurement: VAS test.;Severity of dysmenorrhea. Timepoint: before operation. Method of measurement: VAS test.;Severity of dysmenorrhea. Timepoint: 4 months after starting vitamin D. Method of measurement: VAS test.

Secondary

MeasureTime frame
Dysmenorrhea. Timepoint: 4 months after starting vitamin D. Method of measurement: VAS test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Fariba Almassi

Iran University of Medical Sciences ( IUMS )

dralmassi@yahoo.com+98 21 6650 9283

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026